BCL2L1 and ovarian carcinoma: In addition, our study introduces Beclin 1 protein expression as a new independent prognostic marker in ovarian carcinomas, and more importantly, decreased expression of Beclin 1 synergized with altered Bcl-xL expression in tumor cells predicts poorer outcome of the cancer for the individual patient.